Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-015516
Filing Date
2016-03-29
Accepted
2016-03-29 16:54:49
Documents
94
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ddxs-10k_20151231.htm 10-K 3441596
2 EX-23.1 ddxs-ex231_8.htm EX-23.1 2046
3 EX-31.1 ddxs-ex311_9.htm EX-31.1 17199
4 EX-31.2 ddxs-ex312_10.htm EX-31.2 17200
5 EX-32.1 ddxs-ex321_6.htm EX-32.1 6144
6 EX-32.2 ddxs-ex322_7.htm EX-32.2 6141
  Complete submission text file 0001564590-16-015516.txt   13024592

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ddxs-20151231.xml EX-101.INS 3380057
8 XBRL TAXONOMY EXTENSION SCHEMA ddxs-20151231.xsd EX-101.SCH 71760
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ddxs-20151231_cal.xml EX-101.CAL 57419
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ddxs-20151231_def.xml EX-101.DEF 221796
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ddxs-20151231_lab.xml EX-101.LAB 557697
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ddxs-20151231_pre.xml EX-101.PRE 435026
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-246-6400
Diadexus, Inc. (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 161535881
SIC: 2834 Pharmaceutical Preparations